Telesis Bio Inc. (NASDAQ: TBIO)
$3.57
+0.2100 ( +6.25% ) 41.0K
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
Market Data
Open
$3.57
Previous close
$3.36
Volume
41.0K
Market cap
$5.96M
Day range
$3.38 - $3.64
52 week range
$3.03 - $29.34
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 12, 2024 |
10-q | Quarterly Reports | 90 | May 10, 2024 |
8-k | 8K-related | 13 | May 09, 2024 |
8-k | 8K-related | 14 | May 06, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
ars | Annual reports | 1 | Apr 23, 2024 |